CORSAIR CAPITAL MANAGEMENT, L.P.

Position in HROW — Harrow, Inc.

CIK 1276470 NEW YORK, NY

Back to HROW Full portfolio

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$669,940

+$179,940 QoQ

Shares Held

19,000

+90.0% QoQ

Ownership

0.051%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in HROW Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

CORSAIR CAPITAL MANAGEMENT, L.P. holds $2,460,103 across 5 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (27.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HROW	Harrow, Inc. This page	19,000	$669,940
2	LQDA	Liquidia Corp	15,000	$566,100
3	ASRT	Assertio Holdings, Inc.	25,549	$486,963
4	RMTI	Rockwell Medical, Inc.	50,000	$446,600
5	AQST	Aquestive Therapeutics, Inc.	70,000	$290,500

All Filings in HROW

Export CSV

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$669,940	19,000	+90.0%	Shares	Sole	2026-05-15
2025-12-31	$490,000	10,000	-34.1%	Shares	Sole	2026-02-17
2023-09-30	$217,992	15,170	-0.0%	Shares	Sole	2023-11-13
2023-06-30	$288,970	15,177	0.0%	Shares	Sole	2023-08-14
2023-03-31	$321,145	15,177	-45.2%	Shares	Sole	2023-05-12
2022-12-31	$408,866	27,701	-0.3%	Shares	Sole	2023-02-14
2022-09-30	$335,425	27,790	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.